These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65. Mycophenolate mofetil or tacrolimus compared with intravenous cyclophosphamide in the induction treatment for active lupus nephritis. Li X; Ren H; Zhang Q; Zhang W; Wu X; Xu Y; Shen P; Chen N Nephrol Dial Transplant; 2012 Apr; 27(4):1467-72. PubMed ID: 21917733 [TBL] [Abstract][Full Text] [Related]
66. Treatment of lupus nephritis: practical issues in Asian countries. Yap DY; Chan TM Int J Rheum Dis; 2015 Feb; 18(2):138-45. PubMed ID: 24965809 [TBL] [Abstract][Full Text] [Related]
67. Pharmacological therapy of lupus nephritis. Fine DM JAMA; 2005 Jun; 293(24):3053-60. PubMed ID: 15972568 [TBL] [Abstract][Full Text] [Related]
68. Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of adult and paediatric lupus nephritis. Bertsias GK; Tektonidou M; Amoura Z; Aringer M; Bajema I; Berden JH; Boletis J; Cervera R; Dörner T; Doria A; Ferrario F; Floege J; Houssiau FA; Ioannidis JP; Isenberg DA; Kallenberg CG; Lightstone L; Marks SD; Martini A; Moroni G; Neumann I; Praga M; Schneider M; Starra A; Tesar V; Vasconcelos C; van Vollenhoven RF; Zakharova H; Haubitz M; Gordon C; Jayne D; Boumpas DT; Ann Rheum Dis; 2012 Nov; 71(11):1771-82. PubMed ID: 22851469 [TBL] [Abstract][Full Text] [Related]
69. An Update on the Diagnosis and Management of Lupus Nephritis. Kostopoulou M; Adamichou C; Bertsias G Curr Rheumatol Rep; 2020 Jun; 22(7):30. PubMed ID: 32500443 [TBL] [Abstract][Full Text] [Related]
70. Mycophenolate mofetil for refractory haemolytic anemia in systemic lupus erythematosus. Mak A; Mok CC Lupus; 2005; 14(10):856-8. PubMed ID: 16302683 [TBL] [Abstract][Full Text] [Related]
71. Current and Emerging Therapy on Lupus Nephritis. Bawazier LA Acta Med Indones; 2017 Oct; 49(4):369-377. PubMed ID: 29348390 [TBL] [Abstract][Full Text] [Related]
72. Recent Advances in Treatment Strategies for Lupus Nephritis. Karasawa K; Uchida K; Takabe T; Moriyama T; Nitta K Contrib Nephrol; 2018; 195():42-50. PubMed ID: 29734149 [TBL] [Abstract][Full Text] [Related]
73. Mycophenolate mofetil in lupus nephritis. Ginzler EM; Aranow C Lupus; 2005; 14(1):59-64. PubMed ID: 15732290 [TBL] [Abstract][Full Text] [Related]
74. Mycophenolate mofetil: a magic bullet for lupus? McCune WJ; Riskalla MM J Rheumatol; 2005 Jun; 32(6):967-70. PubMed ID: 15940751 [No Abstract] [Full Text] [Related]
76. Real-World Experience of Safety of Mycophenolate Mofetil in 119 Japanese Patients with Systemic Lupus Erythematosus: A Retrospective Single-Center Study. Abe Y; Tada K; Yamaji K; Tamura N Biomed Res Int; 2021; 2021():8630596. PubMed ID: 33564682 [TBL] [Abstract][Full Text] [Related]
77. Effectiveness of renoprotective approaches for persistent proteinuria in lupus nephritis: more than just immunosuppression. Castro M; Ugolini-Lopes M; Borba EF; Bonfá E; Seguro LPC Lupus; 2018 Dec; 27(14):2215-2219. PubMed ID: 30394834 [TBL] [Abstract][Full Text] [Related]